Cargando…

Management of malignant pleural mesothelioma—part 2: therapeutic approaches: Consensus of the Austrian Mesothelioma Interest Group (AMIG)

Treatment of malignant pleural mesothelioma (MPM) depends on performance status of the patient, tumor stage, and histological differentiation. Chemotherapy (CHT) can be administered as first- and second-line treatment in unresectable MPM or as neoadjuvant or adjuvant treatment before or after surger...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hoda, Mir Alireza, Klikovits, Thomas, Arns, Madeleine, Dieckmann, Karin, Zöchbauer-Müller, Sabine, Geltner, Christian, Baumgartner, Bernhard, Errhalt, Peter, Machan, Barbara, Pohl, Wolfgang, Hutter, Jörg, Eckmayr, Josef, Studnicka, Michael, Flicker, Martin, Cerkl, Peter, Klepetko, Walter
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Vienna 2016
Materias:	Consensus Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5033993/ https://www.ncbi.nlm.nih.gov/pubmed/27457872 http://dx.doi.org/10.1007/s00508-016-1036-3

Ejemplares similares

Management of malignant pleural mesothelioma – part 3: Data from the Austrian Mesothelioma Interest Group (AMIG) database
por: Klikovits, Thomas, et al.
Publicado: (2016)

Management of malignant pleural mesothelioma – part 1: epidemiology, diagnosis, and staging: Consensus of the Austrian Mesothelioma Interest Group (AMIG)
por: Geltner, Christian, et al.
Publicado: (2016)

Results of the Austrian National Lung Cancer Audit
por: Burghuber, Otto C, et al.
Publicado: (2020)

Gender differences in molecular‐guided therapy recommendations for metastatic malignant mesothelioma
por: Taghizadeh, Hossein, et al.
Publicado: (2020)

Circulating fibrinogen is a prognostic and predictive biomarker in malignant pleural mesothelioma
por: Ghanim, B, et al.
Publicado: (2014)

Immunosuppressives and biologics during pregnancy and lactation: A consensus report issued by the Austrian Societies of Gastroenterology and Hepatology and Rheumatology and Rehabilitation
por: Puchner, Antonia, et al.
Publicado: (2019)

Jóvenes amigables /
por: Renault, Mary
Publicado: (1989)

Bioestadística amigable /
Publicado: (2008)

Finanzas amigables /
por: Rossell Alvarez, Carlos
Publicado: (2012)

Bioestadística amigable /
Publicado: (2006)

Bioestadística amigable /
Publicado: (2014)

Indications for liver transplantation in adults: Recommendations of the Austrian Society for Gastroenterology and Hepatology (ÖGGH) in cooperation with the Austrian Society for Transplantation, Transfusion and Genetics (ATX)
por: Graziadei, Ivo, et al.
Publicado: (2016)

Updated Austrian treatment algorithm in HER2+ metastatic breast cancer
por: Bartsch, Rupert, et al.
Publicado: (2022)

Austrian treatment algorithms in HER2-positive metastatic breast cancer: a 2022 update
por: Rinnerthaler, Gabriel, et al.
Publicado: (2022)

Suppression of activin A signals inhibits growth of malignant pleural mesothelioma cells
por: Hoda, M A, et al.
Publicado: (2012)

Austrian consensus on the diagnosis and management of portal hypertension in advanced chronic liver disease (Billroth IV)
por: Mandorfer, Mattias, et al.
Publicado: (2023)

Fibulin-3 levels in malignant pleural mesothelioma are associated with prognosis but not diagnosis
por: Kirschner, Michaela B, et al.
Publicado: (2015)

The FAK inhibitor BI 853520 inhibits spheroid formation and orthotopic tumor growth in malignant pleural mesothelioma
por: Laszlo, Viktoria, et al.
Publicado: (2018)

Austrian consensus guidelines on imaging requirements prior to hepatic surgery and during follow-up in patients with malignant hepatic lesions
por: Tamandl, Dietmar, et al.
Publicado: (2018)

Mesothelioma
por: Rao, Nagarjun, et al.
Publicado: (2022)

Mesothelioma
por: Deraco, Marcello
Publicado: (2021)

Tofacitinib in the treatment of ulcerative colitis: A position paper issued by the Inflammatory Bowel Disease Working Group of the Austrian Society of Gastroenterology and Hepatology (ÖGGH)
por: Kutschera, Maximilian, et al.
Publicado: (2022)

National consensus statement by the Austrian Societies for Rheumatology, Pulmonology, Infectiology, Dermatology and Gastroenterology regarding the management of latent tuberculosis and the associated utilization of biologic and targeted synthetic disease modifying antirheumatic drugs (DMARDs)
por: Rath, Eva, et al.
Publicado: (2022)

Expression of FGFR1–4 in Malignant Pleural Mesothelioma Tissue and Corresponding Cell Lines and its Relationship to Patient Survival and FGFR Inhibitor Sensitivity
por: Vlacic, Gregor, et al.
Publicado: (2019)

Circulating FGF18 is decreased in pleural mesothelioma but not correlated with disease prognosis
por: Mosleh, Berta, et al.
Publicado: (2023)

Circulating complement component 4d (C4d) correlates with tumor volume, chemotherapeutic response and survival in patients with malignant pleural mesothelioma
por: Klikovits, Thomas, et al.
Publicado: (2017)

Ki67 index is an independent prognostic factor in epithelioid but not in non-epithelioid malignant pleural mesothelioma: a multicenter study
por: Ghanim, B, et al.
Publicado: (2015)

Peritoneal mesothelioma.
por: Kealey, W. D., et al.
Publicado: (1993)

Malignant mesothelioma
por: Ruffié, P, et al.
Publicado: (2001)

Peritoneal mesothelioma.
por: Churg, J
Publicado: (1974)

Malignant mesothelioma
por: Moore, Alastair J, et al.
Publicado: (2008)

Malignant mesothelioma
por: Ahmed, Ishtiaq, et al.
Publicado: (2013)

Peritoneal mesothelioma
por: Greenbaum, Alissa, et al.
Publicado: (2020)

Malignant Mesothelioma
por: Pouliquen, Daniel L., et al.
Publicado: (2021)

Controversies in oncology: surgery for small cell lung cancer? It’s time to rethink the case
por: Hoda, Mir Alireza, et al.
Publicado: (2018)

Austrian Lipid Consensus on the management of metabolic lipid disorders to prevent vascular complications: A joint position statement issued by eight medical societies. 2016 update
por: Toplak, Hermann, et al.
Publicado: (2016)

Prognostic impact of PD-1 and PD-L1 expression in malignant pleural mesothelioma: an international multicenter study
por: Brcic, Luka, et al.
Publicado: (2021)

The European mesothelioma epidemic
por: Peto, J, et al.
Publicado: (1999)

MESOTHELIOMA – “NOT JUST IN THE CHEST”
por: Bruckner Holt, Caroline E M, et al.
Publicado: (2008)

Aircraft maintenance and mesothelioma
por: Bianchi, Claudio, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_us31cqleqtpe6u2f54marinsmc